THE VALUE AND DIRECTIONS OF IMPROVING THE INVESTMENT RISK MANAGEMENT PROCESS IN A PHARMACEUTICAL COMPANY

O. V. Kadyrova and Yu. I. Sevostyanov

Business Strategies, 2021, vol. 9, issue 9

Abstract: The article considers investment risk because of the influence of uncertainty on the achievement of the goals of a particular investment project. The results of the analysis of the practice of investment risk management in a particular pharmaceutical company are presented. It is concluded that the exclusion of the stage of its processing from the investment risk management process entails the loss of possible benefits due to the refusal to implement projects based on the results of risk analysis. Improving the investment risk management process is a factor in increasing the value of the company.

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.strategybusiness.ru/jour/article/viewFile/766/629 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aci:journl:y:2021:id:766

DOI: 10.17747/2311-7184-2021-9-260-262

Access Statistics for this article

More articles in Business Strategies from Real Economy Publishing House
Bibliographic data for series maintained by Кузнецов Ð Ð»ÐµÐºÑ ÐµÐ¹ Риколаевич ().